Market LIVE
Published markets; coverage varies by country
Product profile · United States

ROMVIMZA

 ·  Patent Litigation & Settlement History ↓

IngredientVIMSELTINIB
Application typeNDA
Application219304
Product001
Dosage formCAPSULE
RouteORAL
Strength14MG
Approval date2025-02-14
Marketing statusPrescription
Status event—
ApplicantDECIPHERA PHARMS
Product source

Current GenericRadar decision

Year2040
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2040-02-03
Patent anchor2040-02-03
Exclusivity anchor2030-02-14
Protection date2045-04-30
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2040. Anchor type: PATENT. Patent anchor: 2040-02-03. Exclusivity anchor: 2030-02-14. Anchor date: 2040-02-03. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
91812232034-03-14DS/DP —YNTRUE_DS
English description not available.
———
91812232034-03-14ORANGE_BOOK —YNTRUE_DS
English description not available.
———
122854302039-12-23U U-4145NNU
English description not available.
———
122854302039-12-23ORANGE_BOOK U-4145NNU
English description not available.
———
124851202039-12-23U U-4145NNU
English description not available.
———
124851202039-12-23ORANGE_BOOK U-4145NNU
English description not available.
———
125826552039-12-23U U-4145NYU
English description not available.
———
125826552039-12-23ORANGE_BOOK U-4145NYU
English description not available.
———
111035072040-02-03U U-4145NYU
English description not available.
———
111035072040-02-03ORANGE_BOOK U-4145NYU
English description not available.
———
116791102040-02-03U U-4145NYU
English description not available.
———
116791102040-02-03ORANGE_BOOK U-4145NYU
English description not available.
———
124471492044-12-06DP —NNDP
English description not available.
———
124471492044-12-06ORANGE_BOOK —NNDP
English description not available.
———
125287872044-12-06DS/DP —NNDP
English description not available.
———
125287872044-12-06ORANGE_BOOK —NNDP
English description not available.
———
125514832044-12-06DP —NNDP
English description not available.
———
125514832044-12-06ORANGE_BOOK —NNDP
English description not available.
———
126177752044-12-06DS/DP —NNPROCESS
English description not available.
———
126177752044-12-06ORANGE_BOOK —NNPROCESS
English description not available.
———
126438832044-12-06DS/DP —NNDP
English description not available.
———
126438832044-12-06ORANGE_BOOK —NNDP
English description not available.
———
125094432045-04-30DP —NNDP
English description not available.
———
125094432045-04-30ORANGE_BOOK —NNDP
English description not available.
———
126866722045-04-30DP —NNDP
English description not available.
———
126866722045-04-30ORANGE_BOOK —NNDP
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2025-02-142030-02-14English description not available.YY2030-02-14—Source
NCE2025-02-142030-02-14English description not available.YY2030-02-14
NCE
Full coverage date: 2030-02-14
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (15)
TypeDateRoleBasisSource
PATENT2034-03-14HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2039-12-23HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2039-12-23HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2039-12-23HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2040-02-03CANONICAL_ANCHOREnglish description not available.Source
PATENT2040-02-03CANONICAL_ANCHOREnglish description not available.Source
PATENT2044-12-06FTO_TAILEnglish description not available.Source
PATENT2044-12-06FTO_TAILEnglish description not available.Source
PATENT2044-12-06FTO_TAILEnglish description not available.Source
PATENT2044-12-06FTO_TAILEnglish description not available.Source
PATENT2044-12-06FTO_TAILEnglish description not available.Source
PATENT2045-04-30FTO_TAILEnglish description not available.Source
PATENT2045-04-30FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2040-02-03CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.